Ca. Mantz et al., Induction chemotherapy followed by concomitant chemoradiotherapy in the treatment of locoregionally advanced oropharyngeal cancer, CANCER J, 7(2), 2001, pp. 140-148
PURPOSE Locoregionally advanced oropharyngeal cancer has been conventionall
y treated with either surgery and adjuvant radiotherapy or radiotherapy alo
ne, and clinical and functional outcomes have been pear. Chemoradiotherapy
has been demonstrated to improve functional outcome and disease control ove
r conventional treatment in recent randomized head and neck trials. Herein,
we report overall survival, progression-free survival, and patterns of fai
lure in locoregionally advanced oropharyngeal cancer treated with induction
chemotherapy with or without conservative surgery followed by concomitant
chemoradiation.
MATERIALS AND METHODS Three cycles of induction chemotherapy consisting of
cisplatin, 5-fluorouracil, leucovorin, and interferon alpha -2b (PFL-IFN) w
ere followed by conservative, organ-sparing surgery for residual disease. A
ll patients then proceeded to concomitant chemoradiation consisting of seve
n or eight cycles of 5-fluorouracil, hydroxyurea, and a total radiotherapy
dose of roughly 7000 cGy.
RESULTS Sixty-one patients with predominantly stage IV disease were treated
. Clinical complete response was observed in 65% of patients after inductio
n therapy. The median follow-up was 68.0 months for survivors and 39.0 mont
hs for all patients. At 5 years, overall survival is 51%, progression-free
survival is 64%, locoregional control is 70%, and distant control is 89%. L
ocoregional recurrence accounted far 80% of all initial failures. Only five
radical surgeries (none were total glossectomy) were performed for initial
disease control. Treatment-related toxicity accounted for four deaths.
CONCLUSION PR-IFN given with 5-fluorouracil, hydroxyurea, and radiotherapy
produces a high rate of cures with organ preservation in a disease group th
at has traditionally fared poorly. Local and distant disease control and su
rvival rates exceed those observed with more standard treatment approaches
involving surgery and radiotherapy. Further investigation into chemoradioth
erapy as a curative modality for this disease is warranted.